Celltrion to develop oral autoimmune disease treatment with US firm
Celltrion, a leading biopharmaceutical company in South Korea, has partnered with Rani Therapeutics, a US-based clinical-stage biotech company. According to ...
Celltrion, a leading biopharmaceutical company in South Korea, has partnered with Rani Therapeutics, a US-based clinical-stage biotech company. According to ...
Celltrion Group announced on Tuesday that it plans to broaden its diagnostic portfolio for SARS-CoV-2 by introducing antigen and antibody ...
SK Holdings on Monday said that it injected 8 billion won ($6.5 million) in Hummingbird Bioscience to secure novel antibody-based ...
Samsung Biologics announced on Thursday that it signed with Vir Biotechnology Inc. a manufacturing agreement worth approximately $362 million (438 ...
Celltrion said on Thursday that the company started to select through screening the most effective antibodies to neutralize the virus. ...
Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |